Evidence map›Paper›PMID 40508223›Full record

ReviewInternational journal of molecular sciences2025

The Role of the

Maria Eduarda Cardoso de Melo, Letícia Marques Gomes da Silva, Ana Carolina Costa Cavalcante, Josivan Gomes Lima, Julliane Tamara Araújo de Melo Campos

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Maria Eduarda Cardoso de MeloLaboratório de Biologia Molecular e Genômica, Departamento de Biologia Celular e Genética, Centro de Biociências, Universidade Federal do Rio Grande do Norte (UFRN), Natal 59072-900, RN, Brazil.
Letícia Marques Gomes da SilvaLaboratório de Biologia Molecular e Genômica, Departamento de Biologia Celular e Genética, Centro de Biociências, Universidade Federal do Rio Grande do Norte (UFRN), Natal 59072-900, RN, Brazil.
Ana Carolina Costa CavalcanteLaboratório de Biologia Molecular e Genômica, Departamento de Biologia Celular e Genética, Centro de Biociências, Universidade Federal do Rio Grande do Norte (UFRN), Natal 59072-900, RN, Brazil.
Josivan Gomes LimaLaboratório de Genética Molecular e Metabolismo, Instituto de Medicina Tropical do Rio Grande do Norte, Centro de Biociências, Universidade Federal do Rio Grande do Norte (UFRN), Natal 59072-900, RN, Brazil.ORCID 0000-0002-1627-7018
Julliane Tamara Araújo de Melo CamposLaboratório de Biologia Molecular e Genômica, Departamento de Biologia Celular e Genética, Centro de Biociências, Universidade Federal do Rio Grande do Norte (UFRN), Natal 59072-900, RN, Brazil.ORCID 0000-0002-8501-5521

Funding

Conselho Nacional de Desenvolvimento Científico e Tecnológico 403109/2021-3Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) Scholarship to MECM
6 · The paper itself

Abstract

1-Acylglycerol-3-phosphate O-acyltransferase (1-AGPAT) is an enzyme family composed of 11 isoforms. Notably, 1-AGPAT 2, the most studied isoform since its discovery, is a critical enzyme in the triglyceride synthesis pathway, converting lysophosphatidic acid to phosphatidic acid. In addition,

Indexed as

1-Acylglycerol-3-Phosphate O-AcyltransferaseAdipose TissueLipodystrophy, Congenital GeneralizedHumansMutation1-Acylglycerol-3-Phosphate O-Acyltransferaseadipogenesisgenetic lipodystrophylipid metabolismwhite adipose tissue

Identifiers

PMID40508223
PMCPMC12156872

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.